All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy N. AsouKoichi Adachiand the Japan Adult Leukemia Study Group (JALSG) ORIGINAL ARTICLE Pages: S30 - S35
High-dose carboplatin plus paclitaxel with granulocyte colony-stimulating factor and peripheral blood stem-cell support in non-small-cell lung cancer T. C. Shea ORIGINAL ARTICLE Pages: S74 - S78
New concepts in the treatment of breast cancer using high-dose chemotherapy William P. PetersRoger Dansey ORIGINAL ARTICLE Pages: S88 - S93
Chemotherapy: the more, the better in malignant lymphoma? K. Tobinai ORIGINAL ARTICLE Pages: S110 - S114
All-trans retinoic acid significantly increases 5-year survival in patients with acute promyelocytic leukemia: long-term follow-up of the New York study Steven SoignetAaron FleischauerRaymond P. Warrell Jr. ORIGINAL ARTICLE Pages: S25 - S29
Treatment for adult T-cell leukemia S. HanadaAtae UtsunomiyaTerukatsu Arima ORIGINAL ARTICLE Pages: S47 - S50
New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation Kunio KitamuraHitoshi KiyoiTomoki Naoe ORIGINAL ARTICLE Pages: S36 - S41
Importance of dose and dose intensity in the treatment of small-cell lung cancer Nevin Murray REVIEW Pages: S58 - S63
Dose-intensive chemotherapy in extensive-stage small-cell lung cancer S. NegoroNoriyuki MasudaMasahiro Fukuoka ORIGINAL ARTICLE Pages: S70 - S73
Chemotherapy for small-cell lung cancer: more is not better H. SakaKaoru Shimokata ORIGINAL ARTICLE Pages: S107 - S109
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in breast cancer Y. TokudaMasatoshi OhtaToshio Mitomi ORIGINAL ARTICLE Pages: S94 - S99
Pharmacological considerations in high-dose chemotherapy Yasutsuna Sasaki ORIGINAL ARTICLE Pages: S115 - S118
Design and analysis of trials of salvage therapy in acute myelogenous leukemia Elihu EsteyPeter ThallCynthia David ORIGINAL ARTICLE Pages: S9 - S12
New multidrug-resistance-reversing drugs, MS-209 and SDZ PSC 833 M. NaitoTakashi Tsuruo ORIGINAL ARTICLE Pages: S20 - S24
Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin’s lymphoma R. I. Fisher ORIGINAL ARTICLE Pages: S42 - S46
Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies Michinori OguraYoshitoyo KagamiNagoya CD34 Study Group ORIGINAL ARTICLE Pages: S51 - S57
Multidrug resistance: molecular mechanisms and clinical relevance Victor Ling ORIGINAL ARTICLE Pages: S3 - S8
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein B. I. SikicGeorge A. FisherGang Chen ORIGINAL ARTICLE Pages: S13 - S19
High-dose chemotherapy with hematopoietic rescue in breast cancer: from theory to practice W. R. Bezwoda ORIGINAL ARTICLE Pages: S79 - S87